The company's VectRx device is designed to work with MRI scanners to deliver non-invasive, image-guided adjuvant thermal oncology therapy that reverses treatment-resistant hypoxia and promotes a therapeutic immune response, making cancer treatment more effective and humane. NeoTherma Oncology's cutting-edge technology, seamless integration into established MRI treatment suites, and clinical development strategy set them apart as industry innovators with the vision to reimagine cancer treatment.